TELETRADER News
7/20/2020, 7:36 PM (Source: TeleTrader)
more TeleTrader news

China's COVID vaccine to continue testing in Russia

Phase 3 of China's coronavirus vaccine candidate will take place at Smorodintsev Research Institute of Influenza in St. Petersburg, Russia, the medical facility wrote on Monday.

Ad5-vectored COVID-19 vaccine, developed by the Beijing Institute of Biotechnology and CanSino Biologics, showed promising results in the first two phases of the trial, with the goal now being to "demonstrate its effectiveness on a large sampling of volunteers," the institute wrote.

The third phase is scheduled to start mid-August and will involve men and women aged 18-60.

Baha Breaking News (BBN) / BU